Published in J Rheumatol on February 01, 2001
The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord (2003) 3.08
Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther (2009) 1.99
Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res (2006) 1.68
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve (2013) 1.63
Patients with rheumatoid arthritis in clinical care. Ann Rheum Dis (2004) 1.14
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists. BMC Musculoskelet Disord (2009) 1.11
Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials. Ann Rheum Dis (2014) 1.10
Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. J Orthop Surg Res (2015) 1.07
The Minimum Clinically Important Difference of the Patient-rated Wrist Evaluation Score for Patients With Distal Radius Fractures. Clin Orthop Relat Res (2015) 0.98
Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Res Ther (2015) 0.98
Effects of Tai Chi in patients with chronic obstructive pulmonary disease: preliminary evidence. PLoS One (2013) 0.95
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health Qual Life Outcomes (2009) 0.94
Triangulating Clinically Meaningful Change in the Six-minute Walk Test in Individuals with Chronic Heart Failure: A Systematic Review. Cardiopulm Phys Ther J (2012) 0.92
Measuring surgical outcomes in cervical spondylotic myelopathy patients undergoing anterior cervical discectomy and fusion: assessment of minimum clinically important difference. PLoS One (2013) 0.90
Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure. Cardiopulm Phys Ther J (2013) 0.88
Measurement Properties of the Smartphone-Based B-B Score in Current Shoulder Pathologies. Sensors (Basel) (2015) 0.87
Understanding function and other outcomes in cerebral palsy. Phys Med Rehabil Clin N Am (2009) 0.86
Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery. J Bone Joint Surg Am (2012) 0.85
Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 0.83
[Reduction in pain intensity after treatment for chronic back pain. When is it clinically meaningful?]. Schmerz (2007) 0.83
Science of assessment. Ann Rheum Dis (2005) 0.82
The lack of association between changes in functional outcomes and work retention in a chronic disabling occupational spinal disorder population: implications for the minimum clinical important difference. Spine (Phila Pa 1976) (2011) 0.79
Outcome measures in acute gout: a systematic literature review. J Rheumatol (2013) 0.79
Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Med (2017) 0.78
Updating the OMERACT filter: discrimination and feasibility. J Rheumatol (2014) 0.78
Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis. Clin Rheumatol (2016) 0.77
Does roflumilast improve dyspnea in patients with chronic obstructive pulmonary disease? A meta-analysis. J Thorac Dis (2013) 0.77
The Health Impact of Symptomatic Adult Spinal Deformity: Comparison of Deformity Types to United States Population Norms and Chronic Diseases. Spine (Phila Pa 1976) (2016) 0.76
USE OF THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) FOR EVALUATING TREATMENT OUTCOMES WITH TMJMD PATIENTS: A PRELIMINARY STUDY(). J Appl Biobehav Res (2012) 0.75
Improved knee biomechanics among patients reporting a good outcome in knee-related quality of life one year after total knee arthroplasty. BMC Musculoskelet Disord (2017) 0.75
Reliability and Validity of Electro-Goniometric Range of Motion Measurements in Patients with Hand and Wrist Limitations. Open Orthop J (2016) 0.75
The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension. Ann Am Thorac Soc (2016) 0.75
Patient-Reported Measures of Physical Function in Knee Osteoarthritis. Rheum Dis Clin North Am (2016) 0.75
Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: a meta-analysis. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain. J Pain Res (2016) 0.75
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA (1998) 23.39
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) Am J Ind Med (1996) 16.45
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med (1991) 10.55
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am (1993) 7.53
The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol (1998) 7.43
Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) (1998) 6.51
Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med (2000) 6.29
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med (1995) 6.23
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc (1998) 6.21
Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09
Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA (1994) 4.49
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46
Determining the need for hip and knee arthroplasty: the role of clinical severity and patients' preferences. Med Care (2001) 4.27
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med (1994) 3.96
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
The North American spine society lumbar spine outcome assessment Instrument: reliability and validity tests. Spine (Phila Pa 1976) (1996) 3.94
Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation (1993) 3.94
Health-related quality of life after knee replacement. J Bone Joint Surg Am (1998) 3.88
The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75
A connective tissue disease screening questionnaire for population studies. Ann Epidemiol (1995) 3.72
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65
Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65
Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis (2006) 3.48
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Ann Rheum Dis (2008) 3.45
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 3.45
CODIS STR loci data from 41 sample populations. J Forensic Sci (2001) 3.43
Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res (1996) 3.40
A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA (1997) 3.26
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
The MerR heavy metal receptor mediates positive activation in a topologically novel transcription complex. Cell (1989) 3.18
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) 3.00
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol (1997) 2.92
Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum (2000) 2.92
Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol (1998) 2.77
OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol (1993) 2.74
Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev (2002) 2.65
What do we know about the reliability and validity of physical examination tests used to examine the upper extremity? J Hand Surg Am (1999) 2.65
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
The rational clinical examination. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. JAMA (2001) 2.62
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 2.59
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58
Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ (1995) 2.58
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health (1998) 2.53
Validity and responsiveness of the Knee Society Clinical Rating System in comparison with the SF-36 and WOMAC. J Bone Joint Surg Am (2001) 2.53
Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50
Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun (2005) 2.47
Peripheral nerve function in sepsis and multiple organ failure. Chest (1991) 2.46
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Ann Rheum Dis (2008) 2.35
Gender differences in patient preferences may underlie differential utilization of elective surgery. Am J Med (1997) 2.31
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
The characteristics of patient satisfaction measures. Spine (Phila Pa 1976) (2000) 2.24
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol (1995) 2.23
Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ (1997) 2.23
Acetaminophen for osteoarthritis. Cochrane Database Syst Rev (2006) 2.21
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis (2008) 2.19
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Measurement properties of a self-administered outcome measure in lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.16
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14